Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23326,81,0.91 [0.61-1.36],0.6564737176128868
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23820,124,1.18 [0.91-1.53],0.2019765178689301
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23610,866,1.06 [0.95-1.18],0.3135940587692537
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Candidiasis,23844,264,1.02 [0.83-1.25],0.8517957142335085
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23161,2357,1.04 [0.98-1.11],0.2112512015272022
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23377,1763,1.09 [1.01-1.18],0.0203292644620641
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23668,842,1.00 [0.89-1.12],0.9799187406219196
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23773,36,1.08 [0.65-1.81],0.7627791763834234
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22758,550,1.07 [0.93-1.23],0.3258169855453622
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21982,524,1.14 [1.00-1.29],0.0553171900439231
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22206,148,1.03 [0.79-1.35],0.8115220042478972
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17735,1032,1.12 [1.02-1.23],0.0169191845099736
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22008,245,1.12 [0.92-1.36],0.2655242281175894
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23808,982,1.05 [0.95-1.16],0.341148589018906
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Mycoses,23900,320,1.00 [0.83-1.21],0.9941585606163712
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23268,524,1.12 [0.99-1.28],0.0787343114539989
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23847,602,1.05 [0.92-1.20],0.4523889743300572
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22952,126,1.17 [0.91-1.51],0.2278234446461856
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23939,25,1.70 [1.22-2.37],0.0018604979075251
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23776,531,1.05 [0.92-1.21],0.4561133736806867
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23801,64,1.21 [0.86-1.71],0.2783113774889887
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23850,151,1.21 [0.96-1.51],0.1011896560160285
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23836,137,1.30 [1.06-1.61],0.0140265137606884
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23042,298,1.03 [0.85-1.25],0.7518854442153418
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22946,202,1.03 [0.82-1.30],0.7848350460679063
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22890,64,1.21 [0.86-1.71],0.2704820881860891
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23912,45,1.32 [0.90-1.94],0.1494699795334772
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23885,112,0.74 [0.51-1.08],0.1245674689744317
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral warts,23812,39,0.43 [0.20-0.90],0.0258349552471881
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23815,42,1.00 [0.60-1.66],0.9871256672114056
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm,23692,269,1.17 [0.98-1.39],0.0866356652014144
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23864,62,1.09 [0.73-1.61],0.6833604918804455
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23840,67,1.30 [0.96-1.76],0.0949168685358358
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10695,37,1.07 [0.63-1.83],0.80205036318644
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23763,997,0.96 [0.86-1.07],0.4598681604790691
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of meninges,23928,42,1.11 [0.70-1.76],0.6584700872518487
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23907,46,0.60 [0.32-1.13],0.1141861907322766
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23918,78,1.20 [0.88-1.64],0.2598936690993575
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of ovary,13188,85,0.86 [0.58-1.28],0.454822288824552
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23930,238,0.88 [0.69-1.12],0.2942815985267371
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Caecum,23928,178,0.97 [0.75-1.25],0.8127033772861649
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23872,44,0.89 [0.51-1.54],0.6677169989222583
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Descending colon,23933,149,0.82 [0.60-1.12],0.2187957560583412
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Rectum,23901,246,0.81 [0.63-1.03],0.0900479872363785
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23870,462,0.95 [0.81-1.12],0.5232684256934588
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23931,263,1.11 [0.92-1.34],0.2775476389744618
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Carcinoma in situ of breast,11312,75,0.77 [0.50-1.21],0.2570029361955038
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11351,84,0.79 [0.52-1.19],0.2605713731371166
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20656,27,1.07 [0.58-1.99],0.8268912537497778
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20662,33,1.28 [0.83-1.98],0.2562085356150624
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23898,96,0.94 [0.66-1.35],0.7509706499241194
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Haemangioma, any site",23898,94,0.95 [0.66-1.35],0.7613522788370652
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Leiomyoma of uterus,12629,354,0.98 [0.82-1.16],0.7774224639582008
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Lung cancer and mesothelioma,17751,157,0.93 [0.70-1.25],0.6520607167889156
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Lymphoid leukaemia,20655,26,1.14 [0.64-2.03],0.6641719243495097
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20756,127,0.95 [0.70-1.29],0.7489935551776739
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20705,76,1.10 [0.77-1.56],0.60700045752062
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11399,68,1.31 [0.99-1.73],0.0564122487444621
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20673,44,1.02 [0.62-1.69],0.9374466999856924
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20678,49,1.07 [0.68-1.67],0.7847332072261783
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20691,62,0.98 [0.63-1.52],0.9333275579460132
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11379,48,1.48 [1.12-1.96],0.0060021486815103
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20677,48,1.32 [0.93-1.87],0.1259164004873379
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9644,346,1.11 [0.93-1.32],0.2429470881223703
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20713,84,1.05 [0.74-1.49],0.7873817933832599
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20676,47,1.07 [0.67-1.71],0.7678720296086871
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20684,55,0.88 [0.54-1.44],0.6133399936723134
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanocytic naevi,23733,187,1.06 [0.84-1.34],0.6111365874959516
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanocytic naevi of trunk,23897,85,1.00 [0.70-1.43],0.99832489084323
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanoma in situ,20638,38,1.10 [0.68-1.78],0.7003703260155849
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20681,52,1.35 [0.97-1.87],0.0731682024648403
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20725,96,1.29 [0.99-1.67],0.0549648170750787
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20734,105,0.93 [0.67-1.29],0.6755717253004709
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20683,54,1.43 [1.07-1.92],0.0157279124229734
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Other benign neoplasms of skin,23779,128,1.16 [0.90-1.49],0.242260577670212
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21178,549,1.06 [0.93-1.22],0.3567750780975586
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21206,577,1.06 [0.93-1.21],0.3917185349954167
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23690,263,1.12 [0.93-1.35],0.2325960517571428
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22708,41,1.05 [0.64-1.75],0.837243100779564
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23492,65,0.85 [0.54-1.35],0.4921472539325565
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23239,1924,1.09 [1.02-1.17],0.0154807633687799
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22934,20,0.89 [0.40-1.98],0.7724782512610102
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23632,28,1.51 [1.03-2.20],0.034957648492655
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23546,879,1.11 [1.00-1.23],0.0531027501108197
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23546,879,1.11 [1.00-1.23],0.0531027501108197
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22716,49,1.04 [0.65-1.66],0.8699446439539855
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23700,786,1.08 [0.97-1.21],0.1507803780210769
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23696,92,1.22 [0.92-1.62],0.1740437801504207
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23475,48,1.34 [0.93-1.93],0.117844304700844
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23465,38,1.43 [1.00-2.04],0.0504232395025375
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23771,167,1.06 [0.83-1.36],0.6342055567871445
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23871,58,1.16 [0.78-1.70],0.4645403674674173
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23748,144,0.94 [0.70-1.26],0.6653067505594363
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22976,62,0.76 [0.47-1.25],0.2811593336308392
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20544,173,1.08 [0.85-1.38],0.5334989928931673
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22239,105,1.12 [0.84-1.51],0.4360724686681484
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22256,122,1.08 [0.82-1.41],0.5879172179932289
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20402,31,1.36 [0.90-2.07],0.1481705923724069
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22208,63,1.38 [1.03-1.85],0.0286379703713131
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21905,123,1.08 [0.82-1.43],0.5789300647674971
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23814,139,1.06 [0.81-1.39],0.6571779493906124
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23721,46,1.07 [0.68-1.69],0.7722328674986505
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23706,31,1.09 [0.63-1.90],0.7621436725886339
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23588,1443,1.11 [1.02-1.20],0.0117678105405863
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21439,1402,1.09 [1.01-1.18],0.0327115215186843
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20405,34,0.79 [0.40-1.54],0.4839174921745843
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22510,51,0.88 [0.53-1.46],0.6230976175458522
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20531,160,1.29 [1.06-1.58],0.0127951981840859
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20424,53,1.27 [0.89-1.82],0.182730101895722
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22450,2079,1.13 [1.06-1.21],0.0003007052261322
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20479,108,1.22 [0.94-1.59],0.1424573419004579
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20707,336,1.24 [1.07-1.43],0.004943890812259
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23854,225,1.15 [0.94-1.39],0.1666678164993746
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23716,87,1.36 [1.06-1.74],0.0151709778618879
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20461,90,1.30 [0.99-1.72],0.0636618858828789
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20405,34,1.17 [0.71-1.93],0.5279264897698968
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23568,1109,1.08 [0.99-1.19],0.0843708437385341
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20481,110,1.22 [0.93-1.60],0.1500561734629432
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20501,130,1.09 [0.82-1.44],0.5518607610452513
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20717,346,1.02 [0.85-1.22],0.8440196490406254
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20424,53,1.07 [0.69-1.67],0.7556536724852729
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23711,82,1.35 [1.04-1.75],0.0221064607545254
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20630,259,0.96 [0.77-1.19],0.6840563097969619
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20637,266,1.11 [0.92-1.34],0.2846111626620113
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21833,51,1.13 [0.75-1.71],0.548073571054889
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23330,2959,1.10 [1.04-1.17],0.0006439855777858
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22485,26,0.70 [0.32-1.56],0.3869286234868146
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22511,52,1.13 [0.75-1.68],0.5596442275758617
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23779,1681,1.03 [0.95-1.12],0.4504822676119532
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23782,1678,1.03 [0.95-1.12],0.450048198675967
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22490,31,1.17 [0.71-1.92],0.5361507670731664
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23661,1067,1.04 [0.94-1.15],0.4173071205611626
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21138,767,1.08 [0.97-1.21],0.1689826979259192
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23931,110,1.13 [0.84-1.51],0.4084740479064713
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23704,29,0.78 [0.38-1.64],0.5174693419584299
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22672,78,1.11 [0.79-1.56],0.5387295544415378
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22691,97,1.19 [0.90-1.58],0.2186870416027578
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20480,109,1.17 [0.89-1.53],0.2513138303666949
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22374,106,1.33 [1.04-1.71],0.0236301142068917
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1489,57,0.59 [0.33-1.03],0.0650620517442402
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1585,165,1.04 [0.81-1.34],0.7688046310348228
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22304,36,1.13 [0.65-1.98],0.6589815887594586
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1463,31,1.39 [0.87-2.24],0.1669621687378559
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23580,1312,1.13 [1.04-1.23],0.0053359171096003
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23735,60,0.93 [0.59-1.48],0.7651558186576274
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22026,244,0.99 [0.80-1.23],0.9224608721313874
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20718,347,1.18 [1.01-1.38],0.033212173507086
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23860,149,0.74 [0.53-1.03],0.0726404331178117
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23283,47,0.96 [0.57-1.61],0.885679458217741
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Angina pectoris,22831,700,0.98 [0.86-1.12],0.7580196842134774
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23326,90,0.93 [0.63-1.35],0.6887345233696309
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23266,30,1.36 [0.84-2.18],0.2093924349739952
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23332,96,1.17 [0.87-1.57],0.3124771549342875
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16983,783,1.04 [0.92-1.17],0.5351324309017138
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,AV-block,21795,158,0.77 [0.56-1.05],0.0980603890881138
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23909,225,1.00 [0.80-1.25],0.975109258811908
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cardiac arrest,16294,94,1.25 [0.94-1.67],0.1233956880424734
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21748,111,0.85 [0.60-1.22],0.3822131787811567
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21706,69,0.85 [0.54-1.34],0.4787170111307868
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23941,15,1.31 [0.69-2.50],0.4058322681442692
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Conduction disorders,22100,463,1.00 [0.86-1.17],0.9928134258187292
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23290,1169,1.06 [0.96-1.16],0.2436856056827208
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22224,5246,1.09 [1.05-1.14],7.59343497225825e-05
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22936,157,0.74 [0.54-1.02],0.0669603051830915
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Endocarditis,21678,41,0.92 [0.52-1.62],0.7741254226325782
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23832,451,1.08 [0.93-1.25],0.3209896826964605
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypertension,22724,4268,1.09 [1.04-1.14],0.0007912520353466
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22733,4277,1.09 [1.03-1.14],0.0010006577846695
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23783,48,1.07 [0.67-1.71],0.7901926855004279
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18532,76,1.13 [0.79-1.61],0.5053612530648073
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18498,42,1.03 [0.61-1.74],0.9207722213877364
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypotension,23850,597,1.08 [0.95-1.23],0.2162576807115417
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23477,54,0.87 [0.52-1.45],0.5911506428163236
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23438,1307,1.04 [0.95-1.14],0.3887124351553342
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23742,269,1.09 [0.90-1.32],0.387004881305498
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21819,182,0.97 [0.75-1.25],0.7965759962071717
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23717,529,1.06 [0.92-1.22],0.3911147507095379
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22561,430,1.09 [0.94-1.27],0.2703990493718781
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23892,105,0.98 [0.69-1.38],0.8897562976932831
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23926,184,1.03 [0.81-1.32],0.7828811053139669
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Oesophageal varices,22809,30,1.10 [0.63-1.92],0.7326441622313087
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other aneurysm,23277,41,0.75 [0.40-1.40],0.3610329485330041
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other arrhythmias,21858,221,1.16 [0.95-1.41],0.1379111065859099
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23297,61,1.34 [0.96-1.86],0.0815724526541817
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23365,129,1.11 [0.85-1.46],0.4341927276064727
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21749,112,0.79 [0.54-1.13],0.1976938648772901
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other disorders of veins,22840,61,0.81 [0.49-1.32],0.3891324133743794
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22824,45,0.87 [0.51-1.51],0.6310163327808749
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23265,32,0.68 [0.33-1.43],0.3130526266827522
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22859,80,0.89 [0.59-1.33],0.5590005568493042
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22144,507,1.03 [0.89-1.20],0.6648372532202471
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23293,40,0.94 [0.54-1.65],0.8400024442651279
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23540,304,1.03 [0.85-1.24],0.7778482648742766
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23544,135,1.14 [0.88-1.47],0.3235531991918953
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23436,203,0.89 [0.69-1.15],0.3727341659747297
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16412,212,1.12 [0.90-1.38],0.3123404404558677
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23395,180,1.12 [0.89-1.41],0.3371587439590195
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22994,215,0.92 [0.72-1.18],0.5131206673418347
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23700,291,1.12 [0.94-1.34],0.2097514366509847
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23902,279,1.06 [0.88-1.28],0.5482566241309492
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21784,147,1.03 [0.78-1.35],0.8385843371287488
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23541,132,1.14 [0.88-1.47],0.3343100924434898
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23333,100,1.04 [0.75-1.45],0.8170919789316365
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23735,312,1.04 [0.87-1.25],0.6680718529772103
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23712,345,1.03 [0.86-1.23],0.7683569118595794
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23456,47,0.99 [0.60-1.64],0.9789693275673668
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23285,50,0.66 [0.36-1.20],0.1717234277663728
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23590,117,1.26 [0.99-1.61],0.0605416430319826
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23348,160,0.98 [0.75-1.29],0.9125149250152358
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Varicose veins,23049,270,0.91 [0.73-1.13],0.4008814410909173
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23245,42,0.82 [0.45-1.49],0.5222954406512293
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23786,452,1.04 [0.89-1.21],0.6074419204473533
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23797,322,0.95 [0.78-1.16],0.6150986305779196
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21299,1220,1.07 [0.98-1.17],0.1254947386188463
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Any mental disorder,23281,3202,1.02 [0.96-1.08],0.4688709990791241
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23743,376,1.01 [0.85-1.20],0.9302807412205248
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21549,1470,1.09 [1.01-1.18],0.023922168136076
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20156,77,1.00 [0.68-1.46],0.9803221056633308
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Smoking dependency,23467,1346,0.96 [0.87-1.06],0.4181413371532823
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21624,1545,0.97 [0.89-1.06],0.4622451244913462
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Vascular dementia,23841,16,1.59 [0.96-2.64],0.0711263966935472
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Alzheimer disease,23940,64,0.99 [0.65-1.51],0.967968208965912
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Bell's palsy,22479,65,1.04 [0.69-1.55],0.8633096969000069
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22839,425,1.01 [0.87-1.19],0.8631006041084281
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Cerebral cysts,23627,171,1.09 [0.86-1.38],0.4986755065215371
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23862,191,1.04 [0.82-1.32],0.7294114930084472
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23807,21,1.02 [0.50-2.06],0.957257024960776
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23929,49,1.18 [0.79-1.78],0.4210306911509284
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23505,49,1.03 [0.64-1.65],0.9036954660058492
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Epilepsy,22587,227,0.98 [0.78-1.23],0.8590404584165492
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23514,1154,1.03 [0.93-1.13],0.5656529017262079
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23913,166,0.95 [0.72-1.25],0.7060201717803183
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23500,1449,1.08 [0.99-1.17],0.0870684290617406
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Generalized epilepsy,23617,48,1.31 [0.90-1.91],0.1624379998105846
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Hemiplegia,23813,142,1.04 [0.79-1.37],0.7836823905886539
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Hydrocephalus,23498,42,1.25 [0.83-1.90],0.2829844169901634
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23919,60,1.43 [1.08-1.90],0.0135635477213198
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22483,69,0.81 [0.51-1.28],0.3636491355222258
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22485,71,0.98 [0.65-1.47],0.9222608892286251
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Memory loss,23811,66,0.86 [0.55-1.37],0.5351774310573258
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Migraine,22722,362,1.02 [0.86-1.21],0.7883493550012302
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23863,328,1.04 [0.87-1.24],0.6616216347723141
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Motor neuron disease,17404,91,1.00 [0.70-1.42],0.98557274385294
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23750,132,0.84 [0.61-1.17],0.3037539312005572
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23411,997,0.99 [0.89-1.10],0.8233639121675834
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Neurological diseases,22671,2641,1.00 [0.93-1.06],0.9182407403498588
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23855,69,0.99 [0.65-1.49],0.9542888673207226
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22757,343,1.05 [0.88-1.25],0.5924421148028807
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23879,200,1.09 [0.87-1.37],0.4367424460402627
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19972,281,1.00 [0.82-1.22],0.9871177870541498
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23508,52,1.03 [0.65-1.61],0.9139648114976686
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23559,103,1.05 [0.76-1.44],0.7851966658304329
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23817,70,0.89 [0.58-1.38],0.6083659402283704
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22497,83,1.02 [0.71-1.47],0.9003936110045105
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other headache syndromes,22413,53,1.30 [0.92-1.83],0.1343787823985427
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other neurological diseases,23837,381,1.09 [0.93-1.28],0.2735208312645981
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other sleep disorders,22871,511,1.00 [0.86-1.16],0.9591506081964826
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Parkinson's disease,23927,75,0.84 [0.54-1.31],0.449534908256602
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23509,53,1.30 [0.93-1.82],0.1209705018227375
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Restless leg syndrome,23939,32,1.12 [0.66-1.91],0.6670679875621666
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Sleep apnoea,23725,444,1.01 [0.86-1.19],0.894090556736284
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23711,32,1.52 [1.07-2.16],0.0205966285800738
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23924,115,0.88 [0.62-1.24],0.4611511652153178
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22440,26,0.55 [0.23-1.31],0.1770177276877799
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23940,65,1.01 [0.67-1.53],0.9457117642321036
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23829,15,1.54 [0.88-2.67],0.1279151544218441
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23524,35,1.04 [0.60-1.80],0.884786004279581
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23626,180,1.01 [0.79-1.29],0.9349349656504872
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23867,169,1.14 [0.90-1.45],0.2856125415742298
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23282,33,0.88 [0.47-1.65],0.6868890356718081
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23316,67,0.88 [0.56-1.38],0.5847705004097102
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23857,26,1.05 [0.57-1.97],0.8673585221998571
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23773,53,1.17 [0.78-1.74],0.4450043294473937
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1465,33,1.58 [1.06-2.35],0.026109329326872
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1734,68,0.80 [0.50-1.27],0.3374146691139176
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23559,70,1.06 [0.72-1.55],0.7759877695416616
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23832,538,1.06 [0.92-1.22],0.3967936481475883
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23667,418,0.94 [0.79-1.11],0.4623060522294085
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23372,123,1.02 [0.76-1.36],0.907569299514103
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23857,411,0.92 [0.77-1.10],0.3612141092940066
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23933,50,0.79 [0.45-1.36],0.3921349884189343
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23790,344,0.95 [0.79-1.14],0.591630122798084
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23905,185,1.01 [0.79-1.29],0.9326532746210544
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23882,119,0.72 [0.50-1.04],0.0801968187520403
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23264,15,0.75 [0.27-2.11],0.5819991566852847
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23275,26,0.91 [0.45-1.85],0.789883696531779
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23279,30,1.15 [0.69-1.92],0.5983252988727201
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23898,335,1.01 [0.84-1.21],0.8944896625895401
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23647,84,0.78 [0.51-1.19],0.2495500986455829
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23467,21,0.99 [0.48-2.02],0.9700434951541588
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23781,61,1.03 [0.67-1.57],0.9058321406123636
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23846,126,1.04 [0.78-1.38],0.800425813305588
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23590,144,0.95 [0.71-1.27],0.734227828890561
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23831,68,0.69 [0.42-1.13],0.1401257803315866
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23781,218,1.04 [0.83-1.29],0.7451057026205727
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23584,95,1.13 [0.83-1.52],0.4471581695283035
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23323,942,1.06 [0.96-1.18],0.2593373737586539
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23824,104,1.10 [0.81-1.48],0.5415546401758234
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23920,99,1.14 [0.85-1.53],0.3810999831760857
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23478,229,0.90 [0.71-1.14],0.3917949404658644
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23756,36,0.80 [0.42-1.54],0.5074072744325289
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23917,34,0.86 [0.45-1.62],0.6312482801333793
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23282,33,1.00 [0.56-1.78],0.9944178011242502
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23351,102,0.85 [0.58-1.22],0.3736009419658647
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23348,54,0.70 [0.40-1.23],0.217527621801944
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23494,48,0.77 [0.44-1.35],0.3599027063462997
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23340,46,0.82 [0.47-1.43],0.4763756466598119
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23609,46,0.98 [0.60-1.60],0.9444716169980898
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23640,77,1.08 [0.76-1.55],0.6577097369418352
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23323,74,1.15 [0.82-1.61],0.427868103563136
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23401,107,1.22 [0.94-1.59],0.1295998879739041
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23324,30,0.74 [0.35-1.56],0.4299408951020689
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23098,717,1.01 [0.89-1.14],0.8577741581017782
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23293,44,1.32 [0.92-1.88],0.1319360117745079
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23750,261,1.11 [0.92-1.34],0.2960494612541242
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23520,31,0.85 [0.43-1.69],0.6476042149450842
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23599,110,1.16 [0.88-1.54],0.2907193952486263
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23760,55,1.00 [0.64-1.56],0.9978472589291396
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23899,81,0.79 [0.51-1.21],0.2800268181886406
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23830,123,1.03 [0.77-1.38],0.819498966350092
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23754,49,1.34 [0.95-1.89],0.0948119941668906
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23757,52,0.97 [0.60-1.55],0.8932920571408359
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23857,468,1.15 [1.00-1.31],0.0505832489456895
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23675,286,1.17 [0.98-1.38],0.0790730643959986
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23477,88,1.23 [0.92-1.65],0.1557973687371853
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23455,66,1.40 [1.06-1.86],0.0193900796845097
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute pharyngitis,23679,69,0.99 [0.66-1.49],0.9618027072325412
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23825,215,0.98 [0.78-1.24],0.8863824818485547
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23669,59,1.16 [0.79-1.70],0.4446071671864628
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,All influenza,22826,67,1.08 [0.74-1.58],0.696944111412404
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22825,66,1.10 [0.76-1.61],0.6045389949609459
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17711,117,0.89 [0.64-1.24],0.4900487852041765
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Allergic rhinitis,23813,274,1.02 [0.83-1.24],0.8746952869846802
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18997,1537,1.04 [0.96-1.13],0.2881214088885745
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19101,1507,1.05 [0.97-1.14],0.2219907037233151
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23696,84,1.24 [0.93-1.66],0.1446956668181764
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22808,49,1.41 [1.02-1.94],0.0354883278405031
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Bronchiectasis,21283,153,1.18 [0.94-1.49],0.1495743669465954
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21164,34,0.91 [0.49-1.67],0.7564141108886828
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23177,2047,1.04 [0.97-1.12],0.2361199896868954
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22648,59,1.02 [0.66-1.57],0.9305070338343752
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Chronic sinusitis,22730,141,1.17 [0.92-1.49],0.195419776324543
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23851,630,1.04 [0.91-1.18],0.5843143260322359
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Deviated nasal septum,22707,118,0.98 [0.71-1.34],0.8945111039792587
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22257,3686,1.03 [0.97-1.08],0.3487214885907651
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22925,336,1.01 [0.84-1.21],0.9348287141455288
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Early onset COPD,23666,445,1.01 [0.86-1.18],0.9264148317950104
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Emphysema,21293,163,1.22 [0.98-1.52],0.0747171282665339
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22815,99,1.12 [0.83-1.52],0.4394547223989873
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23783,1024,1.02 [0.92-1.13],0.676763056138274
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Interstitial lung disease,22837,121,1.09 [0.83-1.44],0.5421646881130205
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Later onset COPD,22674,185,1.12 [0.90-1.40],0.3094427360033571
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23933,131,0.78 [0.56-1.10],0.161759503062729
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Nasal polyp,22691,102,1.11 [0.82-1.51],0.4830827149462231
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23748,550,1.00 [0.86-1.15],0.945789633030728
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other diseases of pleura,23783,1089,1.15 [1.05-1.25],0.0030324992631096
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23368,779,1.05 [0.94-1.18],0.3801579420595171
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other pleural conditions,22726,32,0.89 [0.47-1.70],0.7328000208529085
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23888,177,1.04 [0.82-1.33],0.7335162690603247
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23866,738,1.14 [1.02-1.27],0.0228155518902028
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pleural effusion,23217,523,1.17 [1.03-1.33],0.0154790497919812
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pleural plaque,22742,48,1.17 [0.77-1.79],0.4558910155215296
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23600,841,0.99 [0.88-1.11],0.867251656172835
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23917,115,0.83 [0.58-1.18],0.2982545929019569
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pneumothorax,22750,56,1.22 [0.84-1.75],0.2935452271977323
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pollen allergy,23910,235,0.98 [0.78-1.22],0.8459585121506119
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pulmonary oedema,23746,35,1.30 [0.85-1.99],0.2249091922197831
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17627,33,1.23 [0.77-1.95],0.3911782992923568
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23728,530,0.98 [0.85-1.14],0.7930910625917187
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22863,274,1.02 [0.84-1.24],0.8504661849679557
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Viral pneumonia,22921,162,0.99 [0.76-1.29],0.9277146302874386
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23711,140,0.90 [0.67-1.22],0.5067471644728286
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13802,86,1.17 [0.86-1.60],0.3249181783567243
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18326,57,0.93 [0.58-1.49],0.7565372970237169
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute appendicitis,23763,131,0.76 [0.54-1.07],0.1169783087670641
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute gastritis,19122,62,0.80 [0.49-1.31],0.3750829956335786
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute pancreatitis,22535,149,1.12 [0.87-1.43],0.3854782212199752
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute peritonitis,23549,58,1.28 [0.92-1.78],0.1494220620558859
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23269,76,1.06 [0.73-1.54],0.7511904609068802
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Barrett oesophagus,19366,306,1.09 [0.91-1.31],0.3334380702413535
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22433,47,1.26 [0.85-1.85],0.2467292580382393
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23593,47,1.26 [0.86-1.86],0.2408327708761551
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Cholecystitis,22539,153,1.03 [0.79-1.34],0.8335115887562532
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Cholelithiasis,23215,829,1.01 [0.90-1.13],0.8661585896335435
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Chronic gastritis,19274,214,0.98 [0.77-1.24],0.8361632021888301
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22422,36,0.72 [0.36-1.42],0.3424341434776358
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23811,76,0.94 [0.62-1.40],0.7494646146426998
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Coeliac disease,22696,94,1.24 [0.95-1.63],0.1184904850366332
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Collagenous colitis,22579,43,0.82 [0.45-1.47],0.4978603782745364
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23773,181,0.87 [0.66-1.15],0.3317048006931467
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Constipation,23744,1010,0.99 [0.89-1.10],0.8495465901143755
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Crohn disease,22612,76,0.78 [0.50-1.22],0.2764363993494074
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23639,50,0.83 [0.48-1.41],0.4870389418396748
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22609,73,0.74 [0.47-1.18],0.2107772163781064
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Dental caries,23217,229,1.07 [0.87-1.32],0.5217658630759813
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22112,1554,1.09 [1.01-1.18],0.0261131711183631
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of appendix,23801,169,0.87 [0.66-1.16],0.350241908417421
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of liver,23833,640,1.00 [0.88-1.14],0.98377584209644
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22413,3353,1.06 [1.00-1.12],0.0460366522959048
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23515,527,1.08 [0.94-1.24],0.2834568393003156
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23863,372,1.11 [0.95-1.29],0.2041921892120725
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23098,110,1.13 [0.85-1.51],0.3885871111856324
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22962,58,1.13 [0.76-1.67],0.5471643681555929
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23692,1090,1.04 [0.95-1.15],0.3934013300199626
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of tongue,22968,106,1.15 [0.87-1.53],0.3288191158407479
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23497,1111,1.00 [0.91-1.11],0.9631928717691484
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20379,2110,1.05 [0.98-1.13],0.1452958102614966
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Duodenal ulcer,19188,128,1.06 [0.80-1.42],0.6718896210330476
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23874,100,0.88 [0.61-1.28],0.5076495818306644
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23824,71,1.26 [0.93-1.71],0.137983035634419
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23286,93,0.90 [0.61-1.31],0.570152605680541
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18425,156,0.74 [0.54-1.01],0.0615283921365988
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Functional dyspepsia,19507,447,1.08 [0.93-1.25],0.3095174572305437
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastric ulcer,19312,252,1.07 [0.87-1.31],0.5061549576410057
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21018,1958,1.08 [1.00-1.16],0.0382941021899
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19425,365,1.05 [0.89-1.25],0.544180429034694
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19472,6942,1.02 [0.98-1.06],0.3179657069331499
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,GI-bleeding,23478,876,1.01 [0.91-1.13],0.8339952996761523
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23047,59,1.17 [0.80-1.72],0.4128455424726641
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19056,1104,1.03 [0.94-1.14],0.5235749106736374
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23237,44,0.94 [0.56-1.60],0.8302991042889906
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Hernia,22912,2354,1.08 [1.01-1.15],0.0275133871891554
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Impacted teeth,23833,66,1.37 [1.04-1.82],0.0273922193580381
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Impaction of intestines,18301,32,1.22 [0.75-1.97],0.4279627513765143
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Inguinal hernia,21154,596,0.99 [0.85-1.14],0.8439247509644245
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20629,71,1.06 [0.71-1.57],0.7837658141176324
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18329,60,1.10 [0.74-1.63],0.6478684731381619
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22716,114,1.22 [0.95-1.57],0.1243245001703146
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18765,496,1.05 [0.91-1.21],0.4957587410472026
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23915,332,1.08 [0.91-1.28],0.3780209413406066
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23140,604,1.04 [0.92-1.19],0.5300703908819493
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23295,759,1.05 [0.94-1.18],0.3987216965921224
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19185,125,1.20 [0.93-1.56],0.1635039360398804
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oesophagitis,19481,421,0.97 [0.82-1.15],0.711400267798082
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23901,116,1.17 [0.89-1.52],0.2567409827746619
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20601,43,1.24 [0.81-1.88],0.3158086460581134
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19397,1128,0.96 [0.86-1.06],0.404091588767714
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22555,169,1.16 [0.93-1.45],0.1864469958981884
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22526,140,0.78 [0.56-1.08],0.137324580709668
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of intestine,19584,1315,0.97 [0.88-1.07],0.5463206465467313
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of intestines,22490,4221,1.00 [0.95-1.05],0.9581859470824028
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22967,166,1.08 [0.85-1.38],0.5328854926407222
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of liver,23708,515,0.98 [0.85-1.14],0.8387344432909828
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19529,469,1.08 [0.93-1.25],0.3006912996806073
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22460,74,0.98 [0.66-1.46],0.9184705272410504
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23818,327,1.07 [0.90-1.27],0.4184174060241052
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19727,667,1.11 [0.99-1.25],0.0775054277266287
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23490,888,1.01 [0.91-1.13],0.8348655707834568
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23134,146,1.06 [0.82-1.39],0.6483260400336532
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19321,1052,1.01 [0.92-1.12],0.7731496652860004
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20592,1532,1.10 [1.01-1.19],0.0204280534339516
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23263,70,1.21 [0.86-1.69],0.2782211962022708
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23196,660,1.01 [0.89-1.15],0.822711484190285
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18476,207,1.17 [0.95-1.43],0.1346528452699744
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23808,83,1.16 [0.84-1.59],0.367098161623942
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18572,303,1.07 [0.90-1.29],0.4408741953117827
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22723,121,1.09 [0.82-1.44],0.5654711897050372
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23930,53,1.27 [0.90-1.80],0.1685243760674842
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22999,112,1.11 [0.84-1.48],0.4655631054163964
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Toxic colitis,22558,22,1.42 [0.88-2.27],0.1492201301543165
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19230,170,1.09 [0.86-1.39],0.4813129464198992
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ulcerative colitis,22666,130,1.26 [1.00-1.57],0.0473470579341537
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22649,113,1.31 [1.04-1.64],0.0194889295215708
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Umbilical hernia,20793,235,0.94 [0.74-1.18],0.5879295453900852
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18361,92,1.03 [0.73-1.44],0.878176415027568
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ventral hernia,20761,203,1.12 [0.91-1.39],0.2919297005559677
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Volvulus,18325,56,0.99 [0.63-1.56],0.9732539297760316
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23899,136,1.01 [0.76-1.34],0.95416914167832
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23708,74,0.78 [0.50-1.22],0.2778527273765768
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22668,133,1.10 [0.85-1.42],0.489852315841575
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23385,484,0.95 [0.82-1.12],0.5647921146153825
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23080,179,0.86 [0.65-1.13],0.28124952285705
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22684,149,1.17 [0.92-1.49],0.2023448420880945
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23714,201,1.13 [0.91-1.39],0.2658265471329066
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23854,341,1.10 [0.93-1.30],0.2456185575434651
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23552,39,1.32 [0.89-1.94],0.1659442672981217
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22676,2242,1.03 [0.96-1.10],0.4005892075160994
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23539,377,0.92 [0.77-1.11],0.3884266116793085
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23426,264,0.97 [0.78-1.20],0.7626298401755365
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23599,698,0.97 [0.85-1.10],0.6472227177994817
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23928,42,1.17 [0.77-1.80],0.4584089661054826
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22590,55,0.84 [0.51-1.39],0.4955134173422774
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23200,38,0.72 [0.37-1.38],0.317467618677205
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23708,195,1.12 [0.91-1.39],0.2910833661538963
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22789,254,1.10 [0.91-1.34],0.3192016682295517
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22567,32,1.07 [0.61-1.88],0.8190211357808093
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23865,65,1.30 [0.95-1.78],0.0973470544399598
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23018,117,1.27 [1.00-1.63],0.0514042197910725
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23764,130,0.77 [0.54-1.08],0.1316735691706426
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23537,24,1.08 [0.56-2.08],0.8217986011439609
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22581,46,0.85 [0.49-1.47],0.5577168988538845
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23497,962,1.14 [1.04-1.26],0.0058052120663017
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22819,284,1.19 [1.01-1.41],0.0418816312420462
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22571,36,1.33 [0.88-2.01],0.1757778900123381
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23870,236,0.84 [0.66-1.07],0.164431941917788
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23567,54,0.78 [0.46-1.33],0.3672072158024675
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23826,192,0.78 [0.59-1.03],0.076409113063378
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23913,150,0.98 [0.74-1.29],0.8743144041589268
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22647,112,0.99 [0.73-1.36],0.966615817150094
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22696,161,1.33 [1.10-1.61],0.0033803966638777
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23907,144,0.99 [0.75-1.30],0.917515096338412
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22648,113,1.26 [0.97-1.63],0.0846435827221464
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23908,108,1.02 [0.75-1.40],0.8817098418233807
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20970,117,1.26 [0.99-1.61],0.0600379542422519
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22313,4040,1.05 [1.00-1.10],0.0677335411807779
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21139,2866,1.05 [0.99-1.11],0.1317466947667092
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20937,84,1.41 [1.10-1.82],0.0066529317126994
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21457,137,1.01 [0.76-1.35],0.9319484092199368
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21465,145,1.11 [0.86-1.43],0.4128519393734537
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23733,105,0.93 [0.66-1.31],0.6868053032137047
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21361,41,0.63 [0.32-1.23],0.1761203373391024
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18931,658,1.06 [0.94-1.20],0.3280557767006715
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23882,113,0.93 [0.67-1.30],0.6835480981531129
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21567,247,1.17 [0.97-1.40],0.0927115080283221
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20904,5427,1.03 [0.99-1.08],0.1837240883682399
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22717,101,1.02 [0.73-1.41],0.9228741097263904
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20959,106,0.88 [0.61-1.27],0.4941324283823257
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21396,543,1.06 [0.93-1.22],0.3976902169480364
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23163,1843,1.06 [0.99-1.15],0.098434785574419
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21056,203,1.20 [0.99-1.46],0.068759149005545
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21110,257,1.17 [0.98-1.40],0.07703123051656
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20989,136,1.17 [0.92-1.50],0.1994624580259823
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23472,34,0.60 [0.29-1.26],0.1786094464091916
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19402,1129,1.06 [0.97-1.17],0.2093968426786235
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18608,335,1.04 [0.87-1.24],0.6792963900308794
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23891,326,1.04 [0.87-1.25],0.6561750547401222
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18338,65,1.05 [0.72-1.55],0.7855536306299924
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18576,303,1.03 [0.86-1.23],0.7509645649151753
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21138,285,0.96 [0.79-1.18],0.7251473201643033
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18943,670,1.10 [0.98-1.24],0.0969129286008776
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21344,24,0.74 [0.33-1.69],0.4744210286591123
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21814,494,1.07 [0.93-1.23],0.3432507991469052
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21573,253,0.99 [0.80-1.22],0.9035809528508688
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18895,622,1.12 [0.99-1.26],0.0623311579683795
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20922,69,1.35 [1.00-1.82],0.0526452736125537
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20907,54,1.26 [0.88-1.81],0.2042583003955017
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22670,54,0.91 [0.56-1.50],0.7138559510645989
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23650,1034,1.03 [0.93-1.13],0.6127299089492084
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23201,585,1.10 [0.97-1.24],0.1448954480198351
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23836,305,1.03 [0.86-1.24],0.7368629676898366
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19833,1560,1.01 [0.93-1.10],0.8425031845810449
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18338,65,1.00 [0.67-1.51],0.9915971699693432
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20921,68,1.23 [0.88-1.74],0.227547847187116
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18299,26,0.83 [0.39-1.75],0.6212460160537951
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18374,101,1.12 [0.84-1.49],0.4453365447575274
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22828,212,1.00 [0.80-1.26],0.9956156944429676
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22832,216,0.89 [0.69-1.14],0.3443486686084915
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23904,75,1.41 [1.09-1.82],0.008758018285022
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22706,1386,1.08 [0.99-1.17],0.0770660910732719
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20962,109,0.78 [0.54-1.14],0.2005827168195003
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18385,112,0.73 [0.50-1.07],0.1066016004760594
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21874,554,0.97 [0.84-1.13],0.7201106081422145
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20063,1790,1.07 [1.00-1.15],0.0643193799051171
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23488,50,0.86 [0.51-1.45],0.5691568918123164
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23918,69,0.84 [0.54-1.32],0.4568811535175556
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20922,69,1.05 [0.71-1.56],0.8090830596507491
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21819,966,1.11 [1.00-1.22],0.0405366286814501
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20914,61,1.15 [0.79-1.70],0.4645692799328759
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19257,984,1.10 [1.00-1.21],0.0621020927094115
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22713,97,1.03 [0.74-1.44],0.8452292498115159
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20911,58,1.07 [0.71-1.63],0.7460450887097214
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21423,103,1.20 [0.92-1.58],0.1788244864380855
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21201,348,1.06 [0.89-1.26],0.5240852767157966
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23624,186,1.04 [0.82-1.30],0.7704858264255035
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21740,420,1.10 [0.94-1.28],0.2220047421005761
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23843,290,1.06 [0.88-1.27],0.545370474158847
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23924,34,1.09 [0.65-1.83],0.7408199037622726
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21033,180,0.99 [0.77-1.27],0.9143767596589608
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19191,534,1.17 [1.03-1.32],0.0145970316908119
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21286,433,1.12 [0.97-1.30],0.1263624982384176
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21003,150,1.26 [1.01-1.56],0.0381370445105091
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18307,34,0.52 [0.24-1.12],0.0943992797297723
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19821,1548,1.09 [1.00-1.17],0.0395621154008895
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18670,397,1.02 [0.87-1.20],0.8090407952846644
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23513,75,1.05 [0.73-1.51],0.7831348543477628
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23873,44,1.10 [0.69-1.74],0.6976581309833123
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22548,26,1.26 [0.73-2.18],0.4067145201645823
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18344,71,0.85 [0.55-1.32],0.471758125142933
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21404,84,1.26 [0.95-1.68],0.1118056992336212
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18582,309,1.05 [0.87-1.25],0.629081338535922
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21092,239,0.97 [0.78-1.22],0.8104760435216838
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21508,188,1.22 [1.00-1.49],0.0521314473145416
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21410,90,0.96 [0.67-1.37],0.8218934924246417
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20242,43,1.01 [0.62-1.67],0.9580032773686108
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23927,37,1.09 [0.66-1.80],0.7473846287915842
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21377,524,1.01 [0.87-1.16],0.9271909544236157
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23516,78,0.84 [0.55-1.27],0.3999333613529173
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22990,2137,1.03 [0.96-1.11],0.4039529032214307
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20953,100,0.93 [0.65-1.33],0.6776452356481175
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21632,312,1.08 [0.90-1.29],0.3973517826396521
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22705,167,1.21 [0.98-1.49],0.0813408716559492
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21449,129,1.38 [1.13-1.69],0.001443501444808
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22254,934,1.08 [0.97-1.19],0.1494439644131609
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21933,613,1.07 [0.94-1.22],0.2873679432815769
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20892,39,1.03 [0.60-1.77],0.9032736629722068
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23576,138,1.00 [0.76-1.32],0.9857324185574348
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20990,137,1.09 [0.84-1.42],0.5074377141227199
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20906,53,0.97 [0.61-1.56],0.9126848394150636
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18305,32,1.10 [0.63-1.91],0.7334958069734949
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23492,734,1.14 [1.02-1.27],0.0193796097777303
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9697,64,1.11 [0.77-1.61],0.5710162477302543
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12911,70,0.76 [0.48-1.21],0.2522701860226175
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23683,271,1.01 [0.82-1.24],0.9571563129448633
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23468,56,0.57 [0.32-1.02],0.0577258779375352
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23308,550,1.08 [0.95-1.24],0.2529904242195496
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23786,19,0.90 [0.67-1.19],0.4554030663771178
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23793,163,0.79 [0.58-1.07],0.1282636485784574
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Cystitis,21987,133,0.99 [0.74-1.33],0.9460389499221108
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Dialysis,22799,41,1.61 [1.18-2.19],0.0025318813642059
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10359,973,1.14 [1.03-1.26],0.0107990544153244
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13013,172,0.91 [0.70-1.19],0.488943089120649
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Endometriosis,9747,114,1.07 [0.81-1.42],0.631980368995027
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9970,337,0.81 [0.66-0.99],0.0423015176706011
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10014,381,0.98 [0.82-1.16],0.7895076019800557
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20188,3679,1.09 [1.03-1.14],0.0021257953243163
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23822,55,1.41 [1.02-1.95],0.0372796965434353
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hydrocele,9453,67,1.09 [0.73-1.63],0.684652361596008
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22676,192,1.00 [0.78-1.27],0.9755833848217952
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10040,654,1.13 [1.00-1.28],0.0489947313842861
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12903,206,1.06 [0.86-1.31],0.5617886913947125
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9477,91,0.99 [0.69-1.42],0.9484486422220616
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Irregular menses,12912,109,0.87 [0.61-1.22],0.4083349793107488
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9896,263,0.86 [0.69-1.07],0.1697969575172941
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21908,54,0.93 [0.57-1.51],0.779418712790485
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10868,1235,1.01 [0.93-1.11],0.7589574660942706
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9431,45,0.96 [0.56-1.65],0.8808746064029772
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9718,85,1.16 [0.86-1.56],0.3392239405054034
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23930,35,1.37 [0.92-2.04],0.1210367694919518
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23935,38,0.89 [0.49-1.61],0.7044834721755487
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23182,1328,1.09 [1.00-1.18],0.0507300849168419
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22267,413,1.06 [0.91-1.24],0.4529601733007916
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12896,55,1.01 [0.66-1.55],0.9704949697251036
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23893,263,1.07 [0.88-1.30],0.4784591703372148
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9523,137,1.13 [0.86-1.49],0.3649697322408108
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9488,102,1.18 [0.87-1.59],0.2912844329302674
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9452,66,1.18 [0.81-1.72],0.3829828171597733
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23907,47,1.13 [0.73-1.74],0.5806932812907638
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22828,974,1.11 [1.01-1.22],0.0358176092346325
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12804,107,1.18 [0.91-1.53],0.2091683453059243
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9706,73,0.96 [0.65-1.42],0.8397425581697283
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9840,207,1.13 [0.93-1.37],0.2154325186840944
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9686,53,1.03 [0.67-1.61],0.8783694548026626
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9724,91,0.97 [0.68-1.37],0.8451626349563655
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22705,221,0.96 [0.76-1.21],0.7130372238737229
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23718,88,1.29 [0.98-1.69],0.0696346576685296
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9790,157,1.15 [0.92-1.43],0.2244306283483424
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9701,68,1.08 [0.76-1.53],0.6665514085785635
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10003,370,1.08 [0.93-1.26],0.3282322999393287
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9689,56,1.14 [0.77-1.68],0.5109587592163639
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9965,332,0.97 [0.81-1.17],0.7556145972076939
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23806,39,1.06 [0.63-1.78],0.8179702141489953
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9474,88,1.11 [0.79-1.55],0.5589150368499458
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23782,1298,1.09 [1.00-1.19],0.0448802332747327
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22610,126,1.09 [0.83-1.43],0.529726933026013
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22815,57,1.04 [0.67-1.61],0.8634327140152314
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23472,60,0.81 [0.49-1.33],0.4060739756808215
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22006,152,1.23 [0.98-1.54],0.0682177781120934
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23740,328,0.94 [0.78-1.15],0.5621377361741853
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9718,85,1.28 [1.01-1.64],0.0433762652885126
